Pes Anserinus TendinobursitisNCT01680263
Kinesiotaping in Treatment of Pes Anserinus Tendino-bursitis
A study testing Kinesiotaping and NSAIDs/Physical therapy in people with Pes Anserinus Tendinobursitis, run by Shiraz University of Medical Sciences at 1 site in Iran.
Trial summary
The aim of this study was to determine the effects of kinesiotaping in comparison to NSAIDs and physical therapy in treatment of pes anserinus tendino-bursitis. Read more about this study
- Who is it for?
- Ages 20 to 70 years
- Conditions the study is for
- Pes Anserinus Tendinobursitis
- What is being tested?
- Kinesiotaping and NSAIDs/Physical therapy
- Type of treatment
- Medical device, Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 46 participants
- Where
- 1 siteIran
- Study dates
- Feb 2012to Jul 2012
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 70 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Patients with clinical diagnosis of pes anserinus tendino-bursitis.
Who cannot join
- Previous history of trauma or surgery on the knee joint,
- History of NSAIDs induced acid-peptic disease
- Systemic and rheumatic diseases
Trial locations and contacts
1 site in 1 country.
About this study
The aim of this study was to determine the effects of kinesiotaping in comparison to NSAIDs and physical therapy in treatment of pes anserinus tendino-bursitis.
Read the detailed description
The treatment of pes anserinus tendino-bursitis includes refraining from aggravating activities, local modalities such as heat, ice, ultrasound (US), iontophoresis, phonophoresis, electrical stimulation (ES), nonsteroidal anti-inflammatory drugs (NSAIDs) and injections with either corticosteroids or local anesthetics. Another treatment that seems to have a significant effect on the improvement of the disease is kinesiotaping. Kinesiotaping is a cotton strip with an acrylic adhesive that is used for treating athletic injuries and a variety of physical conditions. The therapeutic effects of the tape is to relax the overused muscles and in rehabilitation to facilitate the underused muscles. Advocates claim that the wave pattern found on the kinesiotaping has a lifting effect on the skin which can diminish swelling and inflammation via improving circulation and reduce pain by removing pressure from pain receptors.
- Conditions
- Pes Anserinus Tendinobursitis
- Being tested
- Kinesiotaping, NSAIDs/Physical therapy
- Keywords
- Kinesiotaping, pes anserinus tendino-bursitis, nonsteroidal anti-inflammatory drugs, physical therapy
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
KinesiotapingDevice
Also called taping
Use of kinesiotaping on the painful area in the form of "space correction". Kinesiotaping was repeated for 3 weeks with 1week interval
NSAIDs/Physical therapyProcedure or surgery
Also called non-steroidal anti-inflammatory drugs, physical therapy
Use of non-steroidal anti-inflammatory drugs and 10 sessions of daily physical therapy.
| Study group | Role | What they receive |
|---|---|---|
| Kinesiotaping | Experimental | Use of kinesiotaping on the painful area in the form of "space correction". Kinesiotaping was repeated for 3 weeks with 1 week interval Receives: Device: Kinesiotaping |
| NSAIDs/Physical therapy | Active comparator | treatment was done with NSAIDs and 10 sessions of daily physical therapy. Receives: Procedure: NSAIDs/Physical therapy |
What is being measured
The primary outcome is the main question the study is designed to answer.
Pain (VAS)and swelling scores
Visual analog scale for pain evaluation Assessment of the local swelling via palpation
Measured: 3 weeks
Secondary outcomes (1)
The number of participants with adverse events
The number of participants with adverse events
Measured: 3 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 Sep 2012 (estimated)
- Study startFeb 2012
- Primary completionJun 2012
- Study completionJul 2012
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Pes Anserinus TendinobursitisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 46 participants (actual)
Sponsor and investigators
- Lead sponsor
- Shiraz University of Medical Sciences
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Kaynoosh Homayouni, Shiraz University of Medical Sciences
- Investigators
- Kaynoosh Homayouni, M.D., Study chair, Shiraz University of Medical SciencesShima Foruzi, M.D., Principal investigator, Shiraz University of Medical SciencesFereshte Kalhori, M.D., Principal investigator, Shiraz University of Medical Sciences
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01680263
- Sponsor's protocol ID
- K Homayouni
- Status last verified
- Sep 2012
- First submitted
- 13 Jul 2012
- Last updated
- 7 Sep 2012
- Results posted
- No
- Data monitoring committee
- No
Publications
Homayouni K, Foruzi S, Kalhori F. Effects of kinesiotaping versus non-steroidal anti-inflammatory drugs and physical therapy for treatment of pes anserinus tendino-bursitis: A randomized comparative clinical trial. Phys Sportsmed. 2016 Sep;44(3):252-6. doi: 10.1080/00913847.2016.1199251. Epub 2016 Jun 22.
PubMed 27276165
Study at a glance
From the registry record, last updated by the sponsor on 7 Sep 2012. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Kinesiotaping in Treatment of Pes Anserinus Tendino-bursitis
- ClinicalTrials.gov ID
- NCT01680263
- Acronym / sponsor ID
- K Homayouni
- Conditions
- Pes Anserinus Tendinobursitis
- Keywords
- Kinesiotaping, pes anserinus tendino-bursitis, nonsteroidal anti-inflammatory drugs, physical therapy
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 46 participants (actual)
- Lead sponsor
- Shiraz University of Medical SciencesUniversity, hospital or other
- Study start
- Feb 2012
- Primary completion
- Jun 2012 (actual)
- Study completion
- Jul 2012 (actual)
- First posted
- 7 Sep 2012 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this study was to determine the effects of kinesiotaping in comparison to NSAIDs and physical therapy in treatment of pes anserinus tendino-bursitis.
Detailed description
The treatment of pes anserinus tendino-bursitis includes refraining from aggravating activities, local modalities such as heat, ice, ultrasound (US), iontophoresis, phonophoresis, electrical stimulation (ES), nonsteroidal anti-inflammatory drugs (NSAIDs) and injections with either corticosteroids or local anesthetics. Another treatment that seems to have a significant effect on the improvement of the disease is kinesiotaping. Kinesiotaping is a cotton strip with an acrylic adhesive that is used for treating athletic injuries and a variety of physical conditions. The therapeutic effects of the tape is to relax the overused muscles and in rehabilitation to facilitate the underused muscles. Advocates claim that the wave pattern found on the kinesiotaping has a lifting effect on the skin which can diminish swelling and inflammation via improving circulation and reduce pain by removing pressure from pain receptors.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Kinesiotaping | Experimental | Device: KinesiotapingUse of kinesiotaping on the painful area in the form of "space correction". Kinesiotaping was repeated for 3 weeks with 1 week interval |
| NSAIDs/Physical therapy | Active comparator | Procedure: NSAIDs/Physical therapytreatment was done with NSAIDs and 10 sessions of daily physical therapy. |
Who may qualify
- Ages
- 20 to 70 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- Patients with clinical diagnosis of pes anserinus tendino-bursitis.
Key exclusion criteria (3 listed)
- Previous history of trauma or surgery on the knee joint,
- History of NSAIDs induced acid-peptic disease
- Systemic and rheumatic diseases
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| KinesiotapingAlso: tapingUse of kinesiotaping on the painful area in the form of "space correction". Kinesiotaping was repeated for 3 weeks with 1week interval | Device | Kinesiotaping |
| NSAIDs/Physical therapyAlso: non-steroidal anti-inflammatory drugs, physical therapyUse of non-steroidal anti-inflammatory drugs and 10 sessions of daily physical therapy. | Procedure or surgery | NSAIDs/Physical therapy |
Primary outcome
Pain (VAS)and swelling scores
Time frame: 3 weeks
Visual analog scale for pain evaluation Assessment of the local swelling via palpation
1 secondary outcome
The number of participants with adverse events
Time frame: 3 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Sep 2012.
- Derived from this study: PubMed 27276165Homayouni K, Foruzi S, Kalhori F. Effects of kinesiotaping versus non-steroidal anti-inflammatory drugs and physical therapy for treatment of pes anserinus tendino-bursitis: A randomized comparative clinical trial. Phys Sportsmed. 2016 Sep;44(3):252-6. doi: 10.1080/00913847.2016.1199251. Epub 2016 Jun 22.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Kaynoosh Homayouni, M.D. study chair
Shiraz University of Medical Sciences
Shima Foruzi, M.D. principal investigator
Shiraz University of Medical Sciences
Fereshte Kalhori, M.D. principal investigator
Shiraz University of Medical Sciences
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Kinesiotaping and NSAIDs/Physical therapy in people with Pes Anserinus Tendinobursitis, run by Shiraz University of Medical Sciences at 1 site in Iran.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 7 Sep 2012. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Iran. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Pain (VAS)and swelling scores (time frame: 3 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT01680263, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Sep 2012.